№ files_lp_4_process_3_133519
Commissioning policy outlining clinical criteria, prescribing responsibilities, and funding conditions governing the use of Tapentadol for severe non-cancer pain in adult patients within the Gloucestershire NHS healthcare system.
Region: Gloucestershire, England, United Kingdom
Healthcare System: National Health Service (NHS)
Type of Document: Commissioning policy and prescribing guidance
Subject: Prescribing policy for Tapentadol in non-cancer pain
Medication: Tapentadol
Controlled Drug Classification: Schedule 2 Controlled Drug
Clinical Area: Pain management
Responsible Organisations: Gloucestershire Clinical Commissioning Group; Gloucestershire Hospitals NHS Foundation Trust
Related Guideline: Gloucestershire Joint Formulary
Prescribers Concerned: Pain consultants, palliative care consultants, General Practitioners
Target Patient Group: Adult NHS patients with severe non-cancer pain
Care Setting: Primary and secondary care within Gloucestershire
Treatment Line Position: Third-line opioid treatment
Funding Priority: Low priority for NHS funding outside formulary recommendations
Monitoring Authority: Clinical Commissioning Group (CCG)
Review Requirement: Six-monthly clinical review and periodic reassessment of efficacy
Policy Scope: Initiation, continuation, and review of Tapentadol prescribing in adults with severe non-cancer pain
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.